Man Group PLC Axogen, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $6.6 Million - $11.2 Million	-546,096 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $2.16 Million - $2.97 Million	116,692 Added 27.18%	546,096 $10.8 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $2.47 Million - $3.73 Million	168,746 Added 64.74%	429,404 $9.04 Million
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $610,882 - $1.37 Million	35,745 Added 15.89%	260,658 $5.33 Million
Q3 2018 Nov 14, 2018	BUY	$34.05 - $55.9 $7.66 Million - $12.6 Million	224,913 New	224,913 $8.29 Million

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $776M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.